Cargando…
Long COVID in Inflammatory Bowel Diseases
Background and aims. SARS-CoV-2-infected patients can experience long-lasting symptoms even after the resolution of the acute infection. This condition, defined as Long COVID, is now recognized as a public health priority and its negative impact on the quality of life of the patients could be more r...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658587/ https://www.ncbi.nlm.nih.gov/pubmed/34884276 http://dx.doi.org/10.3390/jcm10235575 |
_version_ | 1784612765076291584 |
---|---|
author | Salvatori, Silvia Baldassarre, Francesco Mossa, Michelangela Monteleone, Giovanni |
author_facet | Salvatori, Silvia Baldassarre, Francesco Mossa, Michelangela Monteleone, Giovanni |
author_sort | Salvatori, Silvia |
collection | PubMed |
description | Background and aims. SARS-CoV-2-infected patients can experience long-lasting symptoms even after the resolution of the acute infection. This condition, defined as Long COVID, is now recognized as a public health priority and its negative impact on the quality of life of the patients could be more relevant in individuals with debilitating pathologies. We here evaluated the frequency of Long COVID in patients with inflammatory bowel diseases (IBD). Methods. IBD patients afferent for scheduled visits to our tertiary referral center at the Tor Vergata University Hospital, Rome, were recruited from 7 September to 22 October 2021. During the visits, patients were investigated about previous COVID-19 infection and the possible development of Long COVID. Results. Fifty-three out of 528 IBD patients (10%) have had a SARS-CoV-2 infection. Of these, 21 patients (40%) developed Long COVID, and asthenia was the more frequent symptom as it occurred in nearly two-thirds of patients. Patients with Long COVID were more frequently females, while other clinical and demographic characteristics did not differ between patients with Long COVID and those without Long COVID. In particular, the IBD relapses occurred with the same frequency in the two groups. Conclusions. Long COVID appears to be common in IBD patients even though it does not influence the IBD course. |
format | Online Article Text |
id | pubmed-8658587 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86585872021-12-10 Long COVID in Inflammatory Bowel Diseases Salvatori, Silvia Baldassarre, Francesco Mossa, Michelangela Monteleone, Giovanni J Clin Med Communication Background and aims. SARS-CoV-2-infected patients can experience long-lasting symptoms even after the resolution of the acute infection. This condition, defined as Long COVID, is now recognized as a public health priority and its negative impact on the quality of life of the patients could be more relevant in individuals with debilitating pathologies. We here evaluated the frequency of Long COVID in patients with inflammatory bowel diseases (IBD). Methods. IBD patients afferent for scheduled visits to our tertiary referral center at the Tor Vergata University Hospital, Rome, were recruited from 7 September to 22 October 2021. During the visits, patients were investigated about previous COVID-19 infection and the possible development of Long COVID. Results. Fifty-three out of 528 IBD patients (10%) have had a SARS-CoV-2 infection. Of these, 21 patients (40%) developed Long COVID, and asthenia was the more frequent symptom as it occurred in nearly two-thirds of patients. Patients with Long COVID were more frequently females, while other clinical and demographic characteristics did not differ between patients with Long COVID and those without Long COVID. In particular, the IBD relapses occurred with the same frequency in the two groups. Conclusions. Long COVID appears to be common in IBD patients even though it does not influence the IBD course. MDPI 2021-11-26 /pmc/articles/PMC8658587/ /pubmed/34884276 http://dx.doi.org/10.3390/jcm10235575 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Salvatori, Silvia Baldassarre, Francesco Mossa, Michelangela Monteleone, Giovanni Long COVID in Inflammatory Bowel Diseases |
title | Long COVID in Inflammatory Bowel Diseases |
title_full | Long COVID in Inflammatory Bowel Diseases |
title_fullStr | Long COVID in Inflammatory Bowel Diseases |
title_full_unstemmed | Long COVID in Inflammatory Bowel Diseases |
title_short | Long COVID in Inflammatory Bowel Diseases |
title_sort | long covid in inflammatory bowel diseases |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658587/ https://www.ncbi.nlm.nih.gov/pubmed/34884276 http://dx.doi.org/10.3390/jcm10235575 |
work_keys_str_mv | AT salvatorisilvia longcovidininflammatoryboweldiseases AT baldassarrefrancesco longcovidininflammatoryboweldiseases AT mossamichelangela longcovidininflammatoryboweldiseases AT monteleonegiovanni longcovidininflammatoryboweldiseases |